Gartner earned his bachelor’s degree in biochemistry at the University of Houston in 1984 and his doctorate in medicinal chemistry from the University of Washington in 2001. Prior to joining the Notre Dame faculty, he served as a research fellow in the Department of Cell Biology at Harvard Medical School.
Gartner's focus is using chemical tools to solve biological questions. He is working to develop early assessment biomarkers for ovarian cancer. For many types of cancer — such as breast, cervical, colon and prostate — there are standardized screening tests that are sensitive enough to detect the disease in its early stages. To date, there is no such test for ovarian cancer. Gartner will be studying the proteins (biomarkers) released from ovarian cancer cells from women in stages I-IV of the disease in order to better understand the mechanism of disease progression. The goal of this project is to develop a biochip that can detect micro amounts of these proteins at an early stage to allow for more effective therapeutic interventions.
- Research Assistant Professor
- Office: 147B Stepan Hall
- Phone: 631-7348
- Send an email